LeadIQ logo
Learn more at LeadIQ.com

Insights

Executive Appointments Terns Pharmaceuticals has made strategic executive appointments, including a new CEO, CFO, and other key leadership roles, indicating potential interest in new partnerships or collaborations.

Product Launches The recent launch of TERN-501 for the treatment of NASH and the global Phase 1 clinical Trial Design of TERN-701 for Chronic Myeloid Leukemia demonstrate a focus on innovative product development, presenting sales opportunities for related services or products.

Funding and Financial Stability With a recent funding of $150M and revenue in the range of $0-10M, Terns Pharmaceuticals shows financial stability and growth potential, making them a promising target for partnerships or solutions that align with their expansion plans.

Industry Recognition Terns Pharmaceuticals' positive top-line data from clinical studies and notable hires of experienced professionals like Elona Kogan and Scott Harris position the company as an industry leader, indicating strong potential for collaborations with top-tier service providers or product suppliers.

Technology Stack The utilization of advanced technologies such as React, Google Tag Manager, and others in Terns Pharmaceuticals' tech stack showcases a commitment to innovation and digital transformation, highlighting opportunities for tech-related solutions or services tailored to their needs.

Similar companies to Terns Pharmaceuticals

Terns Pharmaceuticals Tech Stack

Terns Pharmaceuticals uses 8 technology products and services including Akamai, Microsoft Word, React, and more. Explore Terns Pharmaceuticals's tech stack below.

  • Akamai
    Content Delivery Network
  • Microsoft Word
    Editors
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Module Federation
    Miscellaneous
  • Google Tag Manager
    Tag Management
  • MediaElement.js
    Video Players

Media & News

Terns Pharmaceuticals's Email Address Formats

Terns Pharmaceuticals uses at least 1 format(s):
Terns Pharmaceuticals Email FormatsExamplePercentage
FLast@ternspharma.comJDoe@ternspharma.com
47%
Last@ternspharma.comDoe@ternspharma.com
6%
FLast@ternspharma.comJDoe@ternspharma.com
47%

Frequently Asked Questions

Where is Terns Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Terns Pharmaceuticals's main headquarters is located at 1065 E Hillsdale Blvd Suite 100 Foster City, California 94404 US. The company has employees across 2 continents, including North AmericaAsia.

What is Terns Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Terns Pharmaceuticals is a publicly traded company; the company's stock symbol is TERN.

What is Terns Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Terns Pharmaceuticals's official website is ternspharma.com and has social profiles on LinkedIn.

How much revenue does Terns Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of November 2024, Terns Pharmaceuticals's annual revenue reached $7.5M.

What is Terns Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Terns Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Terns Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of November 2024, Terns Pharmaceuticals has approximately 64 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: A. B.Chief Executive Officer: S. S.Chief Business Officer: M. S. J.. Explore Terns Pharmaceuticals's employee directory with LeadIQ.

What industry does Terns Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Terns Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Terns Pharmaceuticals use?

Minus sign iconPlus sign icon
Terns Pharmaceuticals's tech stack includes AkamaiMicrosoft WordReactjQueryWebpackModule FederationGoogle Tag ManagerMediaElement.js.

What is Terns Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Terns Pharmaceuticals's email format typically follows the pattern of . Find more Terns Pharmaceuticals email formats with LeadIQ.

How much funding has Terns Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of November 2024, Terns Pharmaceuticals has raised $150M in funding. The last funding round occurred on Sep 10, 2024 for $150M.

When was Terns Pharmaceuticals founded?

Minus sign iconPlus sign icon
Terns Pharmaceuticals was founded in 2017.
Terns Pharmaceuticals

Terns Pharmaceuticals

Biotechnology ResearchCalifornia, United States51-200 Employees

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com.

Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated otherwise.

Section iconCompany Overview

Headquarters
1065 E Hillsdale Blvd Suite 100 Foster City, California 94404 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TERN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $150M

    Terns Pharmaceuticals has raised a total of $150M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $150M.

  • $10M

    Terns Pharmaceuticals's revenue is in the range of $10M

Section iconFunding & Financials

  • $150M

    Terns Pharmaceuticals has raised a total of $150M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $150M.

  • $10M

    Terns Pharmaceuticals's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.